Literature DB >> 21886387

Hematologic changes in visceral leishmaniasis/kala azar.

Neelam Varma, Shano Naseem.   

Abstract

Visceral Leishmaniasis (VL) or Kala Azar is a chronic infectious disease caused by parasites of the Leishmania donovani complex that can cause various hematologic manifestations. It is characterized by fever, enlargement of liver and spleen, weight loss, pancytopenia and hypergammaglobinemia. It is endemic in the Indian subcontinent, mainly seen in the states of Bihar and West Bengal. Patients with VL can present to the haematologist for various haematological problems prior to receiving the diagnosis of VL. Anaemia is the most common haematological manifestation of VL. VL may also be associated with leucopenia, thrombocytopenia, pancytopenia, hemophagocytosis and disseminated intravascular coagulation. Hematological improvement is noted within a week and complete hematological response occurs in 4-6 weeks of treatment. Relapses are rare and increased risk of being diagnosed with hematolymphoid malignancies on long term follow up is not noted.

Entities:  

Keywords:  Anaemia; Hematological changes; Kala Azar; Pancytopenia

Year:  2010        PMID: 21886387      PMCID: PMC3002089          DOI: 10.1007/s12288-010-0027-1

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  22 in total

1.  Kala-azar--progress against a neglected disease.

Authors:  Henry W Murray
Journal:  N Engl J Med       Date:  2002-11-28       Impact factor: 91.245

2.  Studies on the pancytopenia of kala-azar.

Authors:  G E CARTWRIGHT; H L CHUNG; A CHANG
Journal:  Blood       Date:  1948-03       Impact factor: 22.113

3.  Trypanosoma cruzi, Leishmania donovani, and L. mexicana: extract factor that lyses mammalian cells.

Authors:  J A O'Daly; P M Aso
Journal:  Exp Parasitol       Date:  1979-04       Impact factor: 2.011

4.  Platelet function studies in Indian kala-azar.

Authors:  B Dube; A Arora; V P Singh; K Kumar; S Sundar
Journal:  J Trop Med Hyg       Date:  1995-06

5.  Mechanism of anaemia in resistant visceral leishmaniasis.

Authors:  M J Pippard; D Moir; D J Weatherall; H M Lenicker
Journal:  Ann Trop Med Parasitol       Date:  1986-06

Review 6.  Leishmaniasis.

Authors:  B L Herwaldt
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

Review 7.  Immune response to leishmania: paradox rather than paradigm.

Authors:  Parul Tripathi; Vinod Singh; Sita Naik
Journal:  FEMS Immunol Med Microbiol       Date:  2007-08-22

8.  Evaluation of direct agglutination test, rk39 Test, and ELISA for the diagnosis of visceral leishmaniasis.

Authors:  Jharna Mandal; Sumeeta Khurana; M L Dubey; Prateek Bhatia; Neelam Varma; Nancy Malla
Journal:  Am J Trop Med Hyg       Date:  2008-07       Impact factor: 2.345

9.  The haematological manifestations of visceral leishmaniasis in infancy and childhood.

Authors:  N A al-Jurayyan; M N al-Nasser; I M al-Fawaz; I H al Ayed; A S al Herbish; A M al-Mazrou; M O al Sohaibani
Journal:  J Trop Pediatr       Date:  1995-06       Impact factor: 1.165

10.  Fatal haemophagocytic syndrome and hepatitis associated with visceral leishmaniasis.

Authors:  P Mathur; J C Samantaray; P Samanta
Journal:  Indian J Med Microbiol       Date:  2007-10       Impact factor: 0.985

View more
  50 in total

1.  Visceral Leishmaniasis: Kala-azar.

Authors:  R V Nampoothiri; S Sreedharanunni; B A Chhabria; S Jain
Journal:  QJM       Date:  2016-01-21

2.  Association between Insulin-Like Growth Factor-I Levels and the Disease Progression and Anemia in Visceral Leishmaniasis.

Authors:  Flaviane Alves de Pinho; Célia Maria Vieira Vendrame; Bruna Leal Lima Maciel; Lucilene Dos Santos Silva; Samantha Ive Miyashiro; Selma Maria Bezerra Jerônimo; Hiro Goto
Journal:  Am J Trop Med Hyg       Date:  2019-04       Impact factor: 2.345

Review 3.  Prevalence, severity, and pathogeneses of anemia in visceral leishmaniasis.

Authors:  Yasuyuki Goto; Jingjie Cheng; Satoko Omachi; Ayako Morimoto
Journal:  Parasitol Res       Date:  2016-11-07       Impact factor: 2.289

4.  Role of Haematological Changes in Predicting Occurrence of Leishmaniasis- A Study in Kumaon Region of Uttarakhand.

Authors:  Sanjay Singh Chufal; Prabhat Pant; Upasna Chachra; Paramjeet Singh; Naveen Thapliyal; Vinita Rawat
Journal:  J Clin Diagn Res       Date:  2016-05-01

5.  Dissecting pathways to thrombocytopenia in a mouse model of visceral leishmaniasis.

Authors:  Gulab Fatima Rani; Olivier Preham; Helen Ashwin; Najmeeyah Brown; Ian S Hitchcock; Paul M Kaye
Journal:  Blood Adv       Date:  2021-03-23

6.  Saraca asoca seed extract treatment recovers the trace elements imbalances in experimental murine visceral leishmaniasis.

Authors:  Sangita Lahiry; Debasish Bhattacharyya; Anindita Chakraborty; Mathummal Sudarshan; Madhumita Manna
Journal:  J Parasit Dis       Date:  2019-10-26

7.  Alteration of Clinical Chemistry Parameters Among Visceral Leishmaniasis Patients in Western Tigrai, Ethiopia, 2018/2019: A Comparative Cross-Sectional Study.

Authors:  Brhane Tesfanchal; Gebremedhin Gebremichail; Getachew Belay; Gebreslassie Gebremariam; Gebreyohannes Teklehaimanot; Hagos Haileslasie; Getachew Kahsu; Aderajew Gebrewahd; Fitsum Mardu; Gebre Adhanom; Brhane Berhe; Hirut Teame; Aster Tsegaye; Mistire Wolde
Journal:  Infect Drug Resist       Date:  2020-08-26       Impact factor: 4.003

8.  Prevalence, features and risk factors for malaria co-infections amongst visceral leishmaniasis patients from Amudat Hospital, Uganda.

Authors:  Erika van den Bogaart; Marieke M Z Berkhout; Emily R Adams; Pètra F Mens; Elizabeth Sentongo; Dawson B Mbulamberi; Masja Straetemans; Henk D F H Schallig; Francois Chappuis
Journal:  PLoS Negl Trop Dis       Date:  2012-04-10

Review 9.  Immune regulation during chronic visceral leishmaniasis.

Authors:  Rebecca J Faleiro; Rajiv Kumar; Louise M Hafner; Christian R Engwerda
Journal:  PLoS Negl Trop Dis       Date:  2014-07-10

10.  Red cell distribution width and mean platelet volume in patients with irritable bowel syndrome.

Authors:  Gulali Aktas; Aytekin Alcelik; Buket Kin Tekce; Vildan Tekelioglu; Mustafa Sit; Haluk Savli
Journal:  Prz Gastroenterol       Date:  2014-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.